Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-20 Sale | 2026-10-22 6:44 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $35.11 | $7,022,668 | 1,399,154 (Direct) | View |
| 2026-10-01 Sale | 2026-10-05 9:00 pm | Arbutus Biopharma Corp | ABUS | Roivant Sciences Ltd. Director 10% Owner | 8,967,383 | $5 | $44,836,915 | 29,880,079 (Direct) | View |
| 2026-10-01 Sale | 2026-10-05 6:05 pm | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 17,750 | $36.1 | $640,861 | 166,370 (Direct) | View |
| 2026-09-30 Sale | 2026-10-02 5:37 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $36.62 | $7,324,000 | 5,243,988 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 6:43 pm | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 4,938 | $39.74 | $196,230 | 9,900 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 6:42 pm | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 5,112 | $39.74 | $203,152 | 36,108 (Direct) | View |
| 2026-09-08 Sale | 2026-09-10 9:00 pm | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 20,000 | $39.9 | $798,000 | 61,541 (Direct) | View |
| 2026-08-28 Sale | 2026-09-01 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $35.77 | $7,153,393 | 5,443,988 (Direct) | View |
| 2026-08-19 Sale | 2026-08-21 9:00 pm | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 335,174 | $36.88 | $12,360,813 | 58,610,859 (Direct) | View |
| 2026-08-14 Sale | 2026-08-18 9:00 pm | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 664,826 | $36.34 | $24,160,402 | 59,867,941 (Direct) | View |
| 2026-07-27 Sale | 2026-07-29 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $34.95 | $6,990,000 | 5,657,897 (Direct) | View |
| 2026-06-30 Sale | 2026-07-02 7:03 pm | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 10,000 | $34.9 | $349,000 | 81,541 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-23 Option Award | 2026-10-27 6:23 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 810 | $0 | 124,490 (Direct) | View |
| 2026-10-23 Tax Withholding | 2026-10-27 6:22 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 116 | $36.49 | 15,351 (Direct) | View |
| 2026-10-23 Option Award | 2026-10-27 6:22 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 513 | $0 | 15,351 (Direct) | View |
| 2026-10-23 Tax Withholding | 2026-10-27 6:21 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 77 | $36.49 | 112,265 (Direct) | View |
| 2026-10-23 Option Award | 2026-10-27 6:21 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 383 | $0 | 112,265 (Direct) | View |
| 2026-10-16 Tax Withholding | 2026-10-20 5:42 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 19,976 | $33.53 | 18,563,884 (Direct) | View |
| 2026-10-16 Tax Withholding | 2026-10-20 5:41 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 34,638 | $33.53 | 16,549,136 (Direct) | View |
| 2026-10-01 Exercise | 2026-10-05 6:05 pm | N/A 2032-07-19 | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 17,750 | $0 | 166,370 (Direct) | View |
| 2026-10-01 Exercise | 2026-10-05 6:05 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 17,750 | $4.46 | 166,370 (Direct) | View |
| 2026-09-30 Tax Withholding | 2026-10-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 76,171 | $36.57 | 16,583,774 (Direct) | View |
| 2026-09-30 Tax Withholding | 2026-10-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 40,309 | $36.57 | 13,495,893 (Direct) | View |
| 2026-09-30 Tax Withholding | 2026-10-02 5:38 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 46,879 | $36.57 | 18,583,860 (Direct) | View |
| 2026-09-30 Exercise | 2026-10-02 5:37 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 5,243,988 (Direct) | View |
| 2026-09-30 Exercise | 2026-10-02 5:37 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 5,243,988 (Direct) | View |
| 2026-09-20 Tax Withholding | 2026-09-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Humes Jennifer Chief Accounting Officer | 3,880 | $39.77 | 106,419 (Direct) | View |
| 2026-09-20 Tax Withholding | 2026-09-22 6:26 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,129 | $39.77 | 269,681 (Direct) | View |
| 2026-09-16 Option Award | 2026-09-18 9:00 pm | N/A 2036-09-15 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 15,585 | $0 | 1,763,988 (Direct) | View |
| 2026-09-16 Option Award | 2026-09-18 7:12 pm | N/A 2036-09-15 | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 15,585 | $0 | 8,976,346 (Direct) | View |
| 2026-09-16 Option Award | 2026-09-18 7:06 pm | N/A 2036-09-15 | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 15,585 | $0 | 134,211 (Direct) | View |
| 2026-09-16 Option Award | 2026-09-18 7:01 pm | N/A 2036-09-15 | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 15,585 | $0 | 122,490 (Direct) | View |
| 2026-09-16 Option Award | 2026-09-18 6:57 pm | N/A 2036-09-15 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 15,585 | $0 | 51,693 (Direct) | View |
| 2026-09-16 Option Award | 2026-09-18 6:56 pm | N/A 2036-09-15 | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 15,585 | $0 | 25,485 (Direct) | View |
| 2026-09-10 Tax Withholding | 2026-09-14 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 5,133 | $40.94 | 8,960,761 (Direct) | View |
| 2026-09-10 Tax Withholding | 2026-09-14 6:42 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 2,378 | $40.94 | 118,626 (Direct) | View |
| 2026-09-10 Tax Withholding | 2026-09-14 6:34 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 2,179 | $40.94 | 14,838 (Direct) | View |
| 2026-09-10 Tax Withholding | 2026-09-14 6:29 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 1,743 | $40.94 | 41,220 (Direct) | View |
| 2026-09-10 Tax Withholding | 2026-09-14 6:25 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 2,905 | $40.94 | 106,905 (Direct) | View |
| 2026-09-08 Exercise | 2026-09-10 9:00 pm | N/A 2033-04-19 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 20,000 | $0 | 61,541 (Direct) | View |
| 2026-09-08 Exercise | 2026-09-10 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 20,000 | $8.8 | 61,541 (Direct) | View |
| 2026-08-28 Exercise | 2026-09-01 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 5,443,988 (Direct) | View |
| 2026-08-28 Exercise | 2026-09-01 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 5,443,988 (Direct) | View |
| 2026-08-20 Tax Withholding | 2026-08-24 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 5,749 | $36.84 | 271,810 (Direct) | View |
| 2026-08-20 Tax Withholding | 2026-08-24 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 13,909 | $36.84 | 1,599,154 (Direct) | View |
| 2026-08-19 Exercise | 2026-08-21 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 335,174 | $0 | 58,610,859 (Direct) | View |
| 2026-08-19 Exercise | 2026-08-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 335,174 | $3.85 | 58,610,859 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 664,826 | $0 | 59,867,941 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 664,826 | $3.85 | 59,867,941 (Direct) | View |
| 2026-07-27 Exercise | 2026-07-29 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 5,657,897 (Direct) | View |
| 2026-07-27 Exercise | 2026-07-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 5,657,897 (Direct) | View |
| 2026-07-17 Option Award | 2026-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 405 | $0 | 109,810 (Direct) | View |
| 2026-07-17 Option Award | 2026-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 543 | $0 | 17,017 (Direct) | View |
| 2026-07-17 Option Award | 2026-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 775 | $0 | 121,004 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 7:06 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 76,171 | $35.39 | 16,659,945 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 7:03 pm | N/A 2033-04-19 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 10,000 | $0 | 81,541 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 7:03 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 10,000 | $8.8 | 81,541 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 7:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 40,310 | $35.39 | 13,536,202 (Direct) | View |